Sporos Bioventures
Harold Levy is the co-founder of Iridian Asset Management, which came to fruition in 1996. Previously, Harold worked as a portfolio manager with Arnhold and S. Bleichroeder, Inc. and served as a research analyst with Lehman Brothers Kuhn Loeb and E.M. Warburg, Pincus & Company. Harold holds a BA in economics from Wesleyan University and an M.B.A. from the University of Chicago.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Sporos Bioventures
Sporos is transforming knowledge into new hope for patients. With deep roots in Texas, connections within Texas Medical Center (TMC) and reach across the industry, the Company identifies novel disease mechanisms and strategically deploys talent, capital and access to operational resources to catalyze the development of breakthrough medicines. Sporos’ current pipeline is diversified across four entities and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease.